In October 2022, FIDEC received formal recognition from the World Health Organization (WHO) for its invaluable contribution to the development and global rollout of the novel oral polio vaccine type 2 (nOPV2). In a letter addressed to FIDEC, WHO DirectorGeneral Dr. Tedros Adhanom Ghebreyesus highlighted the impact of nOPV2 in controlling outbreaks of circulating vaccinederived poliovirus type 2 and acknowledged FIDEC’s role in advancing a more sustainable path toward polio eradication.
World Health Organization (WHO) recognition 2022
